http://articles.mercola.com/sites/articles/archive/2000/03/19/obesity-drugs-lung-cancer.aspxObesity drugs pulled from the market due to reports of heart complications may also have played a role in the rise in the number of cases of a rare lung disorder in the US. Dexfenfluramine and fenfluramine are anti-obesity drugs withdrawn from the marketenCommunityServer 2008.5 SP1 (Build: 31106.3070)